T1	Participants 156 188	Patients with Raynaud's syndrome
T2	Participants 445 508	healthy volunteers and patients with primary Raynaud's syndrome
T3	Participants 681 751	20 patients with severe Raynaud's syndrome, and ten healthy volunteers
